期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

宫颈癌肿瘤微环境的研究进展 被引量：4

原文传递
导出
摘要 肿瘤微环境是肿瘤细胞赖以生存的复杂环境。近年来研究发现,肿瘤微环境在肿瘤的发生、发展、侵袭及转移中扮演着重要的角色。宫颈癌是女性最常见的恶性肿瘤之一,其死亡率逐年增加且发病呈年轻化趋势,严重威胁女性健康。深入了解肿瘤微环境与宫颈癌发生、发展的关系能帮助我们更有效地预防、治疗宫颈癌及拟定风险评估方案。本文旨在对宫颈癌微环境的最新研究进展做一综述。
作者 陈晓静 王薇 陈春林
机构地区 南方医科大学南方医院妇产科
出处 《中国妇幼保健》 CAS 2015年第9期1465-1468,共4页 Maternal and Child Health Care of China
基金 国家自然科学基金〔81372781 81072132〕 广东省自然科学基金〔S2013010014663〕 教育部新世纪优秀人才〔NECT-12-0646〕
关键词 肿瘤微环境 宫颈肿瘤 细胞分化 成纤维细胞 基质细胞 女性健康 细胞增殖 血管内皮细胞 类细胞因子 生长因子
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献21

  • 1Fidler IJ. The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited [J] . Nat Rev Cancer, 2003, 3 (6) : 453 -458. 被引量：1
  • 2Murata T, Mizushima H, Chinen I, et al. HB - EGF and PDGF Mediate reciprocal interactions of carcinoma cells with cancer - associated fibroblasts to support progression of uterine cervical cancers[J] .Cancer Res, 2011, 71 (21): 6633 - 6642. 被引量：1
  • 3Erez N, Truitt M, Olson P, et al. Cancer - associated fibro- blasts are activated in incipient neoplasia to orchestrate tumor - promoting inflammation in an NF - KB - dependent manner [J] . Cancer Cell, 2010, 17 (2) : 135 -147. 被引量：1
  • 4Ren C, Cheng X, Lu B, et al. Activation of interleukin -6/ signal transducer and activator of transcription 3 by human pap- illomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and parac- rine pathways in tumour [J] .Eur J Canc- er, 2013, 49 (18): 3889-3899. 被引量：1
  • 5Grimm C, Watrowski R, Polterauer S, et al. Vascular endo- thelial growth factor gene polymorphisms and risk of cervical intraepithelial neoplasia [J] . Int J Gynecol Cancer, 2011, 21 (4) : 597 -601. 被引量：1
  • 6Hu X, Xing L, Wei X, et al. Nonangiogenic function of VEGF and enhanced radiosensitivity of HeLa cells by inhibition of VEGF expression [J].0ncol Res, 2012, 20 (2 - 3): 93 - 101. 被引量：1
  • 7Feng Q, Wei H, Morihara J, et al. Th2 type inflammation pro- motes the gradual progression of HPV - infected cervical cells to cervical carcinoma [ J] . Gynecol Oncol, 2012, 127 (2) : 412 -419. 被引量：1
  • 8Deligeoroglou E, Giannouli A, Athanasopoulos N, et al. HPV infection: immunological aspects and their utility in future therapy [J] . Infect Dis Obstet Gynecol, 2013, 11 (2013). 540850. 被引量：1
  • 9Bais AG, Beekmann I, Lindemans J, et al. A shift to a pe- ripheral Th2 - type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions [J ] J Clin Pathol, 2005, 58 (10): 1096-1100. 被引量：1
  • 10李志杰,啜俊波,林楠,刘磊,王晶.宫颈癌组织中Th1/Th2类细胞因子的漂移研究[J].现代生物医学进展,2014,14(7):1357-1360. 被引量：18

二级参考文献43

  • 1陈晓,王宇学.实时荧光定量RT-PCR法检测TNF-α mRNA基因表达[J].现代检验医学杂志,2006,21(4):13-15. 被引量：3
  • 2Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and Ameri- can Society for Clinical Pathology screening guidelines for the preven- tion and early detection of cervical cancer [J]. CA Cancer J Clin, 2012, 62(3): 147-172. 被引量：1
  • 3Eide ML, Debaque H. HPV detection methods and genotyping techniq -ues in screening for cervical cancer[J]. Ann Pathol, 2012, 32(6): e15- 23. 被引量：1
  • 4Wiwanitkit V. Cervista HPV HR Test Kit in Cervical Cancer Screenin- g[J]. J Low Genit Tract Dis, 2013, 17(1): 99. 被引量：1
  • 5Sasagawa T, Takagi H, Makinoda S. Immune responses against human papillomavirus(HPV) infection and evasion of host defense in cervical cancer[J]. J Infect Chemother, 2012, 18(6): 807-815. 被引量：1
  • 6Schwarz TF, Spaczynski M, Schneider A, et al. Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years[J]. Hum Vaccin, 2011, 7(9): 958-965. 被引量：1
  • 7Krohn M, Listing M, Tjahjono G, et al. Depression, mood, stress, and Thl/Th2 immune balance in primary breast cancer patients under- going classical massage therapy[J]. Support Care Cancer, 2011, 19(9): 1303-1311. 被引量：1
  • 8Matsuda A, Furukawa K, Suzuki H, et al. Does impaired TH1/TH2 balance cause postoperative infectious complications in colorectal ca- ncer surgery[J]. J Surg Res, 2007, 139(1): 15-21. 被引量：1
  • 9Xu Y, Gao J, Su Z, et al. Downregulation of Hlx Closely Related to the Decreased Expressions of T-bet and Runx3 in Patients with Gastric Cancer May Be Associated with a Pathological Event Leading to the Imbalance ofThl/Th2[J]. Clin Dev Immunol, 2012, 2012:949821. 被引量：1
  • 10Diaconu CC, Neagu AI, Lungu R, et al. Plasticity of regulatory T cells under cytokine pressure[J]. Roum Arch Microbiol Immunol, 2010, 69 (4): 190-196. 被引量：1

共引文献32

同被引文献54

  • 1TOMAO F, PAPA A, ROSSI L, et al. Angiogenesis and antian- giogenic agents in cervical cancer [ J/OL]. Onco Targets Ther, 2014, 7:2237-2248 [ 2015-10-20 ]. http://www, dovepress. com/angiogenesis-and-antiangiogenic -agents-in-cervical-cancer- peer-reviewed-artiele-OTT. DOI:10.2147/OTT. S68286. 被引量：1
  • 2SECORD A A, BLESSING J A, ARMSTRONG D K, et al. Phase Ⅱ trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growthfactor receptor expression: a gynecologic oncology group study [J]. Gynecol On- col, 2008, 108(3) : 493-499. DOI:10. 1016/j. ygyno. 2007.11. 029. 被引量：1
  • 3TEWARI K S, SILL M W, LONG H J, et al. Improved survival with bevacizumab in advanced cervical cancer [ J ]. N Engl J Med, 2014, 370 ( 8 ) : 734-743. DOI: i0. 1056/NEJ- Moa1309748. 被引量：1
  • 4SUH D H, LEE K, KIM K, et al. Major clinical research advanees in gynecologic cancer in 2014 [J]. J Gyneeol Oneol, 2015, 26(2) : 156-167. DOI:10. 3802/jgo. 2015.26.2. 156. 被引量：1
  • 5SHI Y, TUOKAN T, LIN C, et al. Aquaporin 8 involvement in human cervical cancer SiHaMigration via the EGFR-Erkl/2 path- way [J/OL]. Asian Pac J Cancer Prey, 2014, 15(15): 6391- 6395 [ 2015-10-20 ]. http://koreascience, or. kr/article/Arti- cleFullRecord, jsp?cn = POCPA9_2014_vl 5 n15_6391. DOI: 10. 7314/APJCP. 2014.15.15. 6391. 被引量：1
  • 6LIU J, LIANG Y, LIU T, et al. Anti-EGFR-conjugated hollow gold nanospheres enhance radio-cytotoxic targeting of cervical cancer at megavoltage radiation energies [ J/OL]. Nanoscale Res Lett, 2015, 10:218 [ 2015-10-20 ]. http://nanoscalereslett. springeropen, com/articles/10. 1186/s11671-015-0923-2. DOI: 10.1186/sll 671-015-0923-2. 被引量：1
  • 7BUMRUNGTHAI S, MUNJAL K, NANDEKAR S, et al. Epider- mal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications [ J/ OL]. J Transl Med, 2015, 13:244 [2015-10-201. http://transla- tional-medicine, biomedcentral, corn/articles/10. 1186/s12967-015- 0611-0. DOI:10.1186/s129674315-0611-0. 被引量：1
  • 8AGHAJANIAN C, BLANK S V, GOFF B A, et al. OCEANS: a randomized, double-blind, placebo-controlled phase Ⅲ trial of chemotherapy with or without bevacizumab in patients with plati- num-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer[ J]. J Clin Oncol, 2012, 30 (17) : 2039- 2045. DOI : 10. 1200/JCO. 2012.42. 0505. 被引量：1
  • 9KURTZ J E, HARDY-BESSARD A C, DESLANDRES M, et al. Cetuximab, topotecan andcisplatin for the treatment of advanced cervical cancer: a phase Ⅱ GINECO trial [J]. Gynecol Oncol, 2009, 113 ( 1 ) : 16-20. DOI : 10. 1016/j. ygyno. 2008.12. 040. 被引量：1
  • 10KANG S, DONG S M, KIM B R, et al. Thioridazine induces ap- optosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells [ J]. Apoptosis, 2012, 17 (9) : 989-997. DOI : 10, 1007/s10495-012-0717-2. 被引量：1

引证文献4

二级引证文献22

中国妇幼保健
2015年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部